Literature DB >> 18639376

MicroRNAs in the pathogenesis of neuroblastoma.

Johannes H Schulte1, Sebastian Horn, Stefanie Schlierf, Alexander Schramm, Lukas C Heukamp, Holger Christiansen, Reinhard Buettner, Bernd Berwanger, Angelika Eggert.   

Abstract

MicroRNAs constitute a family of small RNA species that regulate translation and stability of mRNA. This additional layer of epigenetic regulation has escaped discovery until recently, and introduces another level between mRNA expression profiling and proteomics. Since microRNAs are involved in regulating most, if not all cellular processes, their involvement in oncogenesis was anticipated. Indeed, soon after their discovery, microRNAs were found to act as tumor suppressor genes by blocking the translation of oncogenes and act as oncogenes by inhibiting the translation of tumor suppressor genes. Here we review the most recent attempts aiming to analyze the functional roles of microRNAs in neuroblastoma, the most devastating solid tumor in childhood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639376     DOI: 10.1016/j.canlet.2008.06.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

Authors:  Salvador Meseguer; Giridhar Mudduluru; Juan Manuel Escamilla; Heike Allgayer; Domingo Barettino
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

2.  miR-506 suppresses neuroblastoma metastasis by targeting ROCK1.

Authors:  Dianguo Li; Yanhua Cao; Jinliang Li; Jialong Xu; Qian Liu; Xiaogang Sun
Journal:  Oncol Lett       Date:  2016-11-29       Impact factor: 2.967

Review 3.  microRNA control of mouse and human pluripotent stem cell behavior.

Authors:  Tobias S Greve; Robert L Judson; Robert Blelloch
Journal:  Annu Rev Cell Dev Biol       Date:  2013-07-12       Impact factor: 13.827

4.  Myc proteins as therapeutic targets.

Authors:  W C Gustafson; W A Weiss
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

5.  Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.

Authors:  Johannes H Schulte; Tobias Marschall; Marcel Martin; Philipp Rosenstiel; Pieter Mestdagh; Stefanie Schlierf; Theresa Thor; Jo Vandesompele; Angelika Eggert; Stefan Schreiber; Sven Rahmann; Alexander Schramm
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

6.  CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation.

Authors:  David M Burns; Andrea D'Ambrogio; Stephanie Nottrott; Joel D Richter
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

7.  A very rare adult case with neuroblastoma.

Authors:  Fatih Selcukbiricik; Deniz Tural; Nihal Esatoglu; Sinem Kocak; Nil Molinas Mandel
Journal:  Case Rep Oncol       Date:  2011-09-23

Review 8.  MiRNA Influences in Neuroblast Modulation: An Introspective Analysis.

Authors:  Vanessa Zammit; Byron Baron; Duncan Ayers
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

9.  MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.

Authors:  Kai-Liang Zhang; Xuan Zhou; Lei Han; Lu-Yue Chen; Ling-Chao Chen; Zhen-Dong Shi; Ming Yang; Yu Ren; Jing-Xuan Yang; Thomas S Frank; Chuan-Bao Zhang; Jun-Xia Zhang; Pei-Yu Pu; Jian-Ning Zhang; Tao Jiang; Eric J Wagner; Min Li; Chun-Sheng Kang
Journal:  Mol Cancer       Date:  2014-03-20       Impact factor: 27.401

10.  MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.

Authors:  Ziran Wang; Hongyan Lei; Quanyu Sun
Journal:  Oncol Rep       Date:  2016-02-26       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.